Lumretuzumab (Anti-ERBB3 / HER3)
Lumretuzumab (Anti-ERBB3 / HER3) is an immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. MW: 147.16 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2902 |
| Sku # | A2902-1mg*25 |
| Pricing | 1mg*25, $4170.00 |